Duphalyte Solution For Injection
Revised: June 2016
Amended Pages
SUMMARY OF PRODUCT CHARACTERISTICS
NAME OF THE VETERINARY MEDICINAL PRODUCT
DUPHALYTE Solution for injection
QUALITATIVE AND QUANTITATIVE COMPOSITION
|
Active substances: |
||
|
|
Composition per ml |
|
|
VITAMINS |
Thiamine Hydrochloride |
0.167 mg |
|
|
Riboflavin (as Riboflavin sodium phosphate) |
0.084mg |
|
|
Pyridoxine Hydrochloride |
0.20mg |
|
|
Cyanocobalamin |
0.05mcg |
|
|
Nicotinamide |
2.25mg |
|
|
Dexpanthenol |
0.10mg |
|
ELECTROLYTES |
Calcium chloride hexahydrate |
0.23mg |
|
|
Magnesium Sulphate heptahydrate |
0.29mg |
|
|
Potassium chloride |
0.20mg |
|
Excipients: |
||
|
|
Methyl hydroxybenzoate (preservative) |
1.80mg |
|
|
Propyl hydroxybenzoate (preservative) |
0.20mg |
|
|
Phenol (preservative) |
0.10mg |
|
|
Disodium edetate dehydrate (preservative) |
0.15mg |
For a full list of excipients, see section 6.1.
PHARMACEUTICAL FORM
Solution for injection.
A clear yellow solution.
CLINICAL PARTICULARS
Target species
Horses, dogs, cats, swine and cattle.
Indications for use, specifying the target species
As supportive maintenance therapy in conditions of fluid loss in horses, cattle, pigs, dogs and cats.
Contraindications
None
Special warnings for each target species
None
Special precautions for use
Special precautions for use in animals
Aseptic precautions must be observed when using the product.
Administer very slowly when the injection is given intravenously. Too rapid injection may cause nausea and distress. If this occurs, discontinue until animal returns to normal and continue at slower rate.
The product should be at normal body temperature when administered.
When administered to calves or young pigs by the subcutaneous route, pain may occur at the injection site. This is usually of a transient nature. Care should be taken to reduce such reactions to a minimum. For welfare reasons it is essential that adequate instructions are given to operators.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
Care should be taken to avoid accidental self-injection.
Wash hands after use.
Adverse reactions (frequency and seriousness)
None known
Use during pregnancy, lactation or lay
The product may be used in pregnant and lactating animals.
Interaction with other medicinal products and other forms of interaction
None known
Amounts to be administered and administration route
Duphalyte should be administered:
To horses:
By slow intravenous injection only.
To cattle and pigs:
By slow intravenous injection only.
To calves and young pigs under three years of age:
Following initial intravenous administration, follow-up therapy, if required, may be administered by the subcutaneous route. In such cases, the dose should be divided and administered at two or more sites.
To cats and dogs:
By slow intravenous injection only.
Recommended doses:
Horses, cattle, sows and boars:
Up to 100ml per 50kg bodyweight.
Foals, calves and younger pigs:
Up to 30ml per 5kg bodyweight.
Dogs and cats:
Up to 50ml per 5kg bodyweight.
Overdose (symptoms, emergency procedures, antidotes), if necessary
Excessive or continuous usage should be avoided because of interactions with dietary vitamins or minerals.
Withdrawal periods
Cattle, horses, swine (meat): Zero days
Cattle (milk): Zero hours.
PHARMACOLOGICAL PROPERTIES
Pharmacotherapeutic group: Vitamins, Multivitamins combinations, Multivitamins with minerals
ATCvet Code:QA11AA03
The product consists of a combination of B-complex vitamins, electrolytes, amino acids and dextrose for use as supportive maintenance therapy in conditions of fluid loss.
PHARMACEUTICAL PARTICULARS
List of excipients
Methyl hydroxybenzoate (preservative)
Propyl hydroxybenzoate (preservative)
Phenol (preservative)
Disodium edetate dehydrate (preservative)
Anhydrous Glucose Anhydrous
L-arginine hydrochloride
L-cysteine hydrochloride monohydrate
Monosodium glutamate monohydrate
L-histidine hydrochloride monohydrate
L-isoleucine
L-leucine
L-lysine hydrochloride
L-methionine
DL-phenylalanine
L-threonine
DL-tryptophane
DL-valine
Sodium acetate trihydrate
Citric acid monohydrate (for pH adjustment)
Water for injections
Incompatibilities
As some vitamins are sensitive to oxidising substances and/or pH changes, Duphalyte should not be mixed for administration with any other product. For this reason it is recommended not to mix Duphalyte with other medicinal products.
Shelf life
Shelf-life of the veterinary medicinal product as packaged for sale: 2 years.
Shelf-life after first opening the immediate packaging: 28 days.
Special precautions for storage
Do not store above 25°C.
Do not freeze.
Protect from light.
Following withdrawal of the first dose, use the product within 28 days.
Discard unused material.
Nature and composition of immediate packaging
500ml opaque polypropylene bottles, with chlorobutyl rubber stoppers with aluminium overseals.
Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
MARKETING AUTHORISATION HOLDER
Zoetis UK Limited
5th Floor, 6 St. Andrew Street
London
EC4A 3AE
MARKETING AUTHORISATION NUMBER
Vm42058/4042
DATE OF FIRST AUTHORISATION
25 July 2000
DATE OF REVISION OF THE TEXT
June 2016
27 June 2016
Page 10 of 10